Company profile
UK company 12269783, incorporated on 18 October 2019.
vacv Developing oncolytic viruses as therapeutics for cancer
Vacv Biotherapeutics (UK) Limited is a UK company with status Active founded in 2019 based in London.
Company number 12269783
Financial period: 1 Jan 2024 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last accounts made up date
Last confirmation statement made up date
Company registered at Companies House
Biotherapeutics company developing cancer treatments and vaccines using patented technology in oncolytic viruses.
N/A
1 Sep 2024 to 31 Aug 2026
Metastatic (stage 4) colorectal cancer (mCRC) is an almost uniformly lethal disease with only a 14% 5-year survival rate. Current treatment strategies for mCRC are limited and escape form therapeutic control is common. Development of new treatment strategies is therefore imperative. Oncolytic viruses (OVs) are attractive therapeutics for cancer as they no...
